Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften Toetsvragen Web-tv Video Audio
Tips voor Mijn BSL
Inloggen
Top
Quality of Life Research
Gepubliceerd in:

01-04-2011

Psychometric evaluation of the Fatigue Severity Scale in patients with major depression

Auteurs: Panagiotis Ferentinos, Vassilis Kontaxakis, Beata Havaki-Kontaxaki, Dimitris Dikeos, Lefteris Lykouras

Gepubliceerd in: Quality of Life Research | Uitgave 3/2011

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

Purpose

This study aimed to investigate the psychometric properties of the Fatigue Severity Scale (FSS), a widely used unidimensional fatigue measure, in patients with major depression.

Methods

Subjects included were 72 patients with major depressive disorder, diagnosed with the DSM-IV based M.I.N.I. 5.0.0., without comorbid fatigue-associated conditions and Hamilton Depression Rating Scale (HDRS) scores ≥ 17 as well as 40 sex- and age-matched healthy controls. The FSS was administered to patients on two time points separated by a 1-week interval and to controls. The vitality subscale of the 36-item Short Form Health Survey (SF-36vit) and a visual analogue fatigue scale (VASF) were also administered.

Results

A total of 79.2% of patients vs. 15% of controls were fatigue cases according to the M.I.N.I. fatigue/energy loss item. The distribution of FSS scores was negatively skewed in the patient group, demonstrating a ceiling effect. The FSS presented satisfactory test–retest reliability (intraclass correlation coefficient 0.993), internal consistency (Cronbach’s α coefficient 0.947), concurrent validity (correlations with SF-36vit, VASF and HDRS were −0.52, 0.73 and 0.32, respectively) and discriminative validity between patients and controls. Factor analysis demonstrated a unidimensional structure. The optimal FSS cutoff score for clinically significant fatigue was 5.4 against the presence of fatigue/energy loss according to the M.I.N.I. as a ‘gold standard’.

Conclusion

When administered to patients with major depression, the FSS was shown to have satisfactory psychometric properties with the exception of a ceiling effect, which may pose limitations to its use in this population.
vorige artikel Development and initial validation of Perceived Rehabilitation Needs Questionnaire for people with schizophrenia
Literatuur
1.
Pawlikowska, T., Chalder, T., Hirsch, S. R., et al. (1994). Population based study of fatigue and psychological distress. British Medical Journal, 308, 763–766.PubMed
2.
David, A., Pelosi, A., McDonald, E., et al. (1990). Tired, weak, or in need of rest: Fatigue among general practice attenders. British Medical Journal, 301, 1199–1202.PubMedCrossRef
3.
Maurice-Tison, S., Verdoux, H., Gay, B., et al. (1998). How to improve recognition and diagnosis of depressive syndromes using international diagnostic criteria. British Journal of General Practice, 48, 1245–1246.PubMed
4.
Tylee, A., Gastpar, M., Lepine, J. P., & Mendlewicz, J. (1999). DEPRES II (Depression Research in European Society II): A patient survey of the symptoms, disability and current management of depression in the community. International Clinical Psychopharmacology, 14, 139–151.PubMed
5.
Demyttenaere, K., De Fruyt, J., & Stahl, S. M. (2005). The many faces of fatigue in major depressive disorder. International Journal of Neuropsychopharmacology, 8, 93–105.PubMedCrossRef
6.
Stahl, S. M., Zhang, L., Damatarca, C., & Grady, M. (2003). Brain circuits determine destiny in depression: A novel approach to the psychopharmacology of wakefulness, fatigue, and executive dysfunction in major depressive disorder. Journal of Clinical Psychiatry, 64(Suppl 14), 6–17.
7.
Paykel, E. S., Ramana, R., Cooper, Z., et al. (1995). Residual symptoms after partial remission: An important outcome in depression. Psychological Medicine, 25, 1171–1180.PubMedCrossRef
8.
Dittner, A. J., Wessely, S. C., & Brown, R. G. (2004). The assessment of fatigue: A practical guide for clinicians and researchers. Journal of Psychosomatic Research, 56, 157–170.PubMedCrossRef
9.
Ferentinos, P. P., Kontaxakis, V. P., Havaki-Kontaxaki, B. J., Paplos, K. G., & Soldatos, C. R. (2007). The measurement of fatigue in depression. Psychopathology, 40, 133–134.PubMedCrossRef
10.
Ferentinos, P., Kontaxakis, V., Havaki-Kontaxaki, B., Dikeos, D., & Papadimitriou, G. (2010). The Fatigue Questionnaire: Standardization in patients with major depression. Psychiatry Research, 177, 114–119.PubMedCrossRef
11.
Krupp, L. B., LaRocca, N. G., Muir-Nash, J., & Steinberg, A. D. (1989). The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Archives of Neurology, 46, 1121–1123.PubMed
12.
Kleinman, L., Zodet, M. W., Hakim, Z., et al. (2000). Psychometric evaluation of the fatigue severity scale for use in chronic hepatitis C. Quality of Life Research, 9, 499–508.PubMedCrossRef
13.
Mattsson, M., Moller, B., Lundberg, I., Gard, G., & Bostrom, C. (2008). Reliability and validity of the Fatigue Severity Scale in Swedish for patients with systemic lupus erythematosus. Scandinavian Journal of Rheumatology, 37, 269–277.PubMedCrossRef
14.
Merkies, I. S., Schmitz, P. I., Samijn, J. P., van der Meche, F. G., & van Doorn, P. A. (1999). Fatigue in immune-mediated polyneuropathies. European Inflammatory Neuropathy Cause and Treatment (INCAT) Group. Neurology, 53, 1648–1654.PubMed
15.
Abe, K., Takanashi, M., & Yanagihara, T. (2000). Fatigue in patients with Parkinson’s disease. Behavioural Neurology, 12, 103–106.PubMed
16.
Friedberg, F., & Krupp, L. B. (1994). A comparison of cognitive behavioral treatment for chronic fatigue syndrome and primary depression. Clinical Infectious Diseases, 18, S105–S110.PubMed
17.
LaChapelle, D. L., & Finlayson, M. A. (1998). An evaluation of subjective and objective measures of fatigue in patients with brain injury and healthy controls. Brain Injury, 12, 649–659.PubMedCrossRef
18.
Lichstein, K. L., Means, M. K., Noe, S. L., & Aguillard, R. N. (1997). Fatigue and sleep disorders. Behaviour Research and Therapy, 35, 733–740.PubMedCrossRef
19.
Stone, P., Richards, M., A’Hern, R., & Hardy, J. (2000). A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer. Annals of Oncology, 11, 561–567.PubMedCrossRef
20.
Pepper, C. M., Krupp, L. B., Friedberg, F., Doscher, C., & Coyle, P. K. (1993). A comparison of neuropsychiatric characteristics in chronic fatigue syndrome, multiple sclerosis, and major depression. Journal of Neuropsychiatry and Clinical Neurosciences, 5, 200–205.PubMed
21.
DeBattista, C., Doghramji, K., Menza, M. A., Rosenthal, M. H., & Fieve, R. R. (2003). Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: A preliminary double-blind, placebo-controlled study. Journal of Clinical Psychiatry, 64, 1057–1064.PubMedCrossRef
22.
Ninan, P. T., Hassman, H. A., Glass, S. J., & McManus, F. C. (2004). Adjunctive modafinil at initiation of treatment with a selective serotonin reuptake inhibitor enhances the degree and onset of therapeutic effects in patients with major depressive disorder and fatigue. Journal of Clinical Psychiatry, 65, 414–420.PubMedCrossRef
23.
Schwartz, T. L., Azhar, N., Cole, K., et al. (2004). An open-label study of adjunctive modafinil in patients with sedation related to serotonergic antidepressant therapy. Journal of Clinical Psychiatry, 65, 1223–1227.PubMedCrossRef
24.
Lundt, L. (2004). Modafinil treatment in patients with seasonal affective disorder/winter depression: An open-label pilot study. Journal of Affective Disorders, 81, 173–178.PubMedCrossRef
25.
Fava, M., Thase, M. E., & DeBattista, C. (2005). A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness. Journal of Clinical Psychiatry, 66, 85–93.PubMedCrossRef
26.
Sheehan, D. V., Lecrubier, Y., Sheehan, K. H., et al. (1998). The mini-international neuropsychiatric interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry, 59(Suppl 20), 22–33.PubMed
27.
Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 56–62.CrossRef
28.
Fava, G. A., Kellner, R., Munari, F., & Pavan, L. (1982). The Hamilton depression rating scale in normals and depressives. Acta Psychiatrica Scandinavica, 66, 26–32.PubMedCrossRef
29.
Sartorius, N., & Janca, A. (1996). Psychiatric assessment instruments developed by the world health organization. In G. Thornicroft & M. Tansella (Eds.), Mental health outcome measures (pp. 153–177). Berlin: Springer.
30.
Ware, J. E., Snow, K. K., Kosinki, M., & Gandek, B. (1993). SF-36 health survey: Manual and interpretation guide. Boston, MA: The Health Institute.
31.
Shrout, P. E., & Fleiss, J. L. (1979). Intraclass correlations: Uses in assessing rater reliability. Psychological Bulletin, 86, 420–428.PubMedCrossRef
32.
McGraw, K. O., & Wong, S. P. (1996). Forming inferences about some intraclass correlation coefficients. Psychological Methods, 1, 30–46.CrossRef
33.
Altman, D. G. (1996). Inter-rater agreement in practical statistics for medical research. London, UK: Chapman & Hall.
34.
Anderson, K. O., Getto, C. J., Mendoza, T. R., et al. (2003). Fatigue and sleep disturbance in patients with cancer, patients with clinical depression, and community-dwelling adults. Journal of Pain and Symptom Management, 25, 307–318.PubMedCrossRef
35.
Lerdal, A., Wahl, A., Rustoen, T., Hanestad, B. R., & Moum, T. (2005). Fatigue in the general population: A translation and test of the psychometric properties of the Norwegian version of the fatigue severity scale. Scandinavian Journal of Public Health, 33, 123–130.PubMedCrossRef
36.
Loge, J. H., Ekeberg, O., & Kaasa, S. (1998). Fatigue in the general Norwegian population: Normative data and associations. Journal of Psychosomatic Research, 45, 53–65.PubMedCrossRef
37.
Kroenke, K., & Price, R. K. (1993). Symptoms in the community. Prevalence, classification, and psychiatric comorbidity. Archives of Internal Medicine, 153, 2474–2480.PubMedCrossRef
38.
van Nes, S. I., Vanhoutte, E. K., Faber, C. G., et al. (2009). Improving fatigue assessment in immune-mediated neuropathies: The modified Rasch-built fatigue severity scale. Journal of the Peripheral Nervous System, 14, 268–278.PubMedCrossRef
39.
Mills, R., Young, C., Nicholas, R., Pallant, J., & Tennant, A. (2009). Rasch analysis of the Fatigue Severity Scale in multiple sclerosis. Multiple Sclerosis, 15, 81–87.PubMedCrossRef
40.
Lerdal, A., Johansson, S., Kottorp, A., & von Koch, L. (2010). Psychometric properties of the Fatigue Severity Scale: Rasch analyses of responses in a Norwegian and a Swedish MS cohort. Multiple Sclerosis, 16, 733–741.PubMedCrossRef
41.
Winstead-Fry, P. (1998). Psychometric assessment of four fatigue scales with a sample of rural cancer patients. Journal of Nursing Measurement, 6, 111–122.PubMed
42.
MacCallum, R. C., Widaman, K. F., Zhang, S., & Hong, S. (1999). Sample size in factor analysis. Psychological Methods, 4, 84–99.CrossRef
43.
Bryant, F. B., & Yarnold, P. R. (1995). Principal components analysis and exploratory and confirmatory factor analysis. In L. G. Grimm & R. R. Yarnold (Eds.), Reading and understanding multivariale statistics (pp. 99–136). Washington, DC: American Psychological Association.
44.
Roelcke, U., Kappos, L., Lechner-Scott, J., et al. (1997). Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: A 18F-fluorodeoxyglucose positron emission tomography study. Neurology, 48, 1566–1571.PubMed
45.
Bakshi, R., Miletich, R. S., Henschel, K., et al. (1999). Fatigue in multiple sclerosis: Cross-sectional correlation with brain MRI findings in 71 patients. Neurology, 53, 1151–1153.PubMed
46.
Lerdal, A., Celius, E. G., Krupp, L., & Dahl, A. A. (2007). A prospective study of patterns of fatigue in multiple sclerosis. European Journal of Neurology, 14, 1338–1343.PubMedCrossRef
47.
Ferentinos, P., Kontaxakis, V., Havaki-Kontaxaki, B., et al. (2009). Sleep disturbances in relation to fatigue in major depression. Journal of Psychosomatic Research, 66, 37–42.PubMed
48.
Fuhrer, R., & Wessely, S. (1995). The epidemiology of fatigue and depression: A French primary-care study. Psychological Medicine, 25, 895–905.PubMedCrossRef
49.
Papakostas, G. I. (2008). Tolerability of modern antidepressants. Journal of Clinical Psychiatry, 69(Suppl E1), 8–13.PubMed
Metagegevens
Titel
Psychometric evaluation of the Fatigue Severity Scale in patients with major depression
Auteurs
Panagiotis Ferentinos
Vassilis Kontaxakis
Beata Havaki-Kontaxaki
Dimitris Dikeos
Lefteris Lykouras
Publicatiedatum
01-04-2011
Uitgeverij
Springer Netherlands
Gepubliceerd in
Quality of Life Research / Uitgave 3/2011
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-010-9769-3

Andere artikelen Uitgave 3/2011

Presenteeism in college students: reliability and validity of the Presenteeism Scale for Students

Response shift effect on gastrointestinal quality of life index after laparoscopic cholecystectomy

Associations between living arrangements and health-related quality of life of urban elderly people: a study from China

Translation of the Social Difficulties Inventory (SDI-21) into three south Asian languages and preliminary evaluation of SDI-21(Urdu)

  • Brief Communication

Using Rasch analysis to form plausible health states amenable to valuation: the development of CORE-6D from a measure of common mental health problems (CORE-OM)

Comparison of self-reported health-related quality of life between Taiwan hemodialysis and peritoneal dialysis patients: a multi-center collaborative study